PTPA and Hepatic fibrosis: In extension of previous studies which demonstrated anti-fibrotic activities of increased ARNT expression and subsequently increased BMP-signaling in kidney and liver13, our study now demonstrates that enforced ARNT homodimerization through administration of the PP2A inhibitor LB100 also attenuates fibrosis in murine models of kidney and liver fibrosis.